Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia.

MLA

Ikeda, Masashi, et al. “Variants of Dopamine and Serotonin Candidate Genes as Predictors of Response to Risperidone Treatment in First-Episode Schizophrenia.” Pharmacogenomics, vol. 9, no. 10, Oct. 2008, pp. 1437–43. EBSCOhost, https://doi.org/10.2217/14622416.9.10.1437.

APA

Ikeda, M., Yamanouchi, Y., Kinoshita, Y., Kitajima, T., Yoshimura, R., Hashimoto, S., O’Donovan, M. C., Nakamura, J., Ozaki, N., & Iwata, N. (2008). Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia. Pharmacogenomics, 9(10), 1437–1443. https://doi.org/10.2217/14622416.9.10.1437

Chicago

Ikeda, Masashi, Yoshio Yamanouchi, Yoko Kinoshita, Tsuyoshi Kitajima, Reiji Yoshimura, Shuji Hashimoto, Michael C O’Donovan, Jun Nakamura, Norio Ozaki, and Nakao Iwata. 2008. “Variants of Dopamine and Serotonin Candidate Genes as Predictors of Response to Risperidone Treatment in First-Episode Schizophrenia.” Pharmacogenomics 9 (10): 1437–43. doi:10.2217/14622416.9.10.1437.